Freedom Capital upgraded Abbott (ABT) to Buy from Hold with a price target of $120, down from $130. The firm cites long-term prospects of the company’s Exact Sciences integration and the significant pullback in the shares for the upgrade.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ABT: